Citations

Clear

3942 citation(s) found for "To, Van".

Outcomes after liver transplantation using deceased after circulatory death donors: A comparison of outcomes in the UK and the US
Ivanics, Tommy , Claasen, Marco P. A. W. , Patel, Madhukar S. , Giorgakis, Emmanouil , Khorsandi, Shirin Elizabeth , Srinivasan, Parthi , Prachalias, Andreas , Menon, Krishna , Jassem, Wayel , Cerisuelo, Miriam Cortés , Mathur, Amit K. , Walker, Kate , Taylor, Rhiannon , Heaton, Nigel , Mehta, Neil , Segev, Dorry L. , Massie, Allan B. , Meulen, Jan van der , Wallace, David , Khorsandi, Shirin E , Cortes, Miriam , Sayed, Blayne A , Mathur, Amit , Walker, Kate , Taylor, Rhiannon , Heaton, Nigel , Mehta, Neil , Segev, Dorry L , Massie, Allan B , van der Meulen, Jan H P , Sapisochin, Gonzalo , Ivanics, Tommy , Giorgakis, Emmanouil , Sayed, Blayne A. , Sapisochín, Gonzalo , Patel, Madhukar

Mayo Clinic

Liver International | February 4, 2023 | Volume: 43 | Issue: 5 | Pages: 1107-1119

10.1111/liv.15537 | PMID 36737866 Get It

AbstractBackground and AimsIdentifying international differences in utilization and outcomes of liver transplantation (LT) after donation after circulatory death (DCD) donation provides a unique opportunity for benchmarking and population‐level insight.MethodsAdult (≥18 years) LT data between 2008 and 2018 from the UK and US were used to assess mortality and graft failure after DCD LT. We used time‐dependent Cox‐regression methods to estimate hazard ratios (HR) for risk‐adjusted short‐term (0–90 days) and longer‐term (90 days–5 years) outcomes.ResultsOne‐thousand five‐hundred‐and‐sixty LT receipts from the UK and 3426 from the US were included. Over the study period, the use of DCD livers increased from 15.7% to 23.9% in the UK compared to 5.1% to 7.6% in the US. In the UK, DCD donors were older (UK:51 vs. US:33 years) with longer cold ischaemia time (UK: 437 vs. US: 333 min). Recipients in the US had higher Model for End‐stage Liver Disease (MELD) scores, higher body mass index, higher proportions of ascites, encephalopathy, diabetes and previous abdominal surgeries. No difference in the risk‐adjusted short‐term mortality or graft failure was observed between the countries. In the longer‐term (90 days–5 years), the UK had lower mortality and graft failure (adj.mortality HR:UK: 0.63 (95% CI: 0.49–0.80); graft failure HR: UK: 0.72, 95% CI: 0.58–0.91). The cumulative incidence of retransplantation was higher in the UK (5 years: UK: 11.9% vs. 4.6%; p < .001).ConclusionsFor those receiving a DCD LT, longer‐term post‐transplant outcomes in the UK are superior to the US, however, significant differences in recipient illness, graft quality and access to retransplantation were seen between the two countries.
Prognostic value of deep learning based mitotic count in hormonal receptor- and HER2-positive breast cancer
Mercan, Caner , Tessier, Leslie, Tellez, David , Salgado, Roberto , Joensuu, Heikki , Loi, Sherene , Michiels, Stefan , Larsimont, Denis , Wegscheider, Anne-Sophie , Niendorf, Axel, Laak, Jeroen van der , Joensuu, Heikki , Loi, Sherene , Balkenhol, Maschenka C. A. , Sherman, Mark E. , Bult, Peter , Ciompi, Francesco

Mayo Clinic

No container title available | February 3, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2408990/v1 Get It

Abstract The discovery of molecular subtypes has corroborated the heterogeneity of breast cancers. But in clinical routine, treatment selection relies on measuring the aggressiveness of the tumor via histopathology, which is routinely based on grading, a prognostic yet laborious, poorly reproducible, and subjective procedure defined more than 30 years ago, before molecular subtypes existed. In this paper, we present an interpretable deep learning-based computer-aided diagnosis method to automate mitotic count, one of the components of grading; the method complies with current guidelines and automates hot-spot finding on full digital whole-slide images of routinely prepared pathologic slides stained with hematoxylin and eosin. We use the computer model to query the current “one-size-fits-all” mitotic count procedure by investigating subtype-specific prognostic value of mitotic count using an external independent large-scale multicentric dataset of 1,709 breast cancers. We show that for human epidermal growth factor-2 (HER2) positive tumors, mitotic count was not prognostic. In hormone-receptor positive/HER2 negative cancers, an average mitotic count density different from clinically used cut offs predicted worse recurrence free survival in multivariable analysis, adjusted for known clinical prognosticators. We provided some first experimental evidence that the prognostic role of mitotic count should be reviewed.
ROAR ED-SANE: A Retrospective Observational Assessment Review of an Emergency Department Sexual Assault Nurse Examiner Program's Adherence to Centers for Disease Control and Prevention Guidelines for Sexually Transmitted Infections
Nelson, Jennifer , Woolever, Nathan L. , Meyer, Lisa M, Hall, Scott, Stakston, Jaclyn , Dababneh, Ala S. , Roush, Kathleen , Sistine, Michael Van, Tempelis, Jennifer, Dierkhising, Ross , Lessard, Sarah , Nelson, Jennifer M, Woolever, Nathan, Meyer, Lisa, Dababneh, Ala, Van Sistine, Michael, Hall, Scott T.

Mayo Clinic

Sexually Transmitted Diseases | February 2, 2023 | Volume: 50 | Issue: 3 | Pages: 167-171

10.1097/olq.0000000000001745 | PMID 36729982 Get It

Background Sexual assault survivors are at increased risk for sexually transmitted infections. Sexual Assault Nurse Examiner programs guide sexually transmitted infection treatment, monitoring, and follow-up scheduling according to guidelines by the Centers for Disease Control and Prevention (CDC). Reported low rates of provider adherence to CDC treatment guidelines and patient adherence to follow-up necessitate a review of medication prescribing and follow-up scheduling practices, especially at smaller community hospitals in the United States. Methods A retrospective medical record review was conducted to assess adherence rates to CDC guidelines for prescribing practices, scheduling, and follow-up of sexual assault survivors. We included pediatric and adult patients presenting to the emergency department (ED) and participating in the ED Sexual Assault Nurse Examiner program at a rural, community-based teaching hospital in La Crosse, WI, from January 2018 to December 2021. Descriptive statistics were used to evaluate results. Results Analysis included 103 patients. Prescribing adherence to CDC guidelines was >80% for all except human immunodeficiency virus (53.4%), trichomoniasis (68.1%), and hepatitis B (69%). Of the 38 patients who had a follow-up scheduled during their ED encounter, 78.9% attended their scheduled follow-up and 94.7% of those appointments were scheduled within the CDC-recommended time frame, leading to an overall adherence of 40%. Conclusions Adherence rates were high for most prescribing practices, and attendance of scheduled follow-up was higher than expected. Opportunities to improved adherence to CDC guidelines were identified in prescribing for 3 disease states (human immunodeficiency virus, trichomoniasis, and hepatitis B) and in scheduling of follow-up.
Abstract 56: Changes In Cardiovascular Health Within Midlife And From Midlife To Late-life Associated With MRI Markers Of Cerebral Vascular Disease In Late-life
Ji, Yuekai, Empana, Jean‐Philippe , Hughes, Timothy M. , Griswold, Michael , Sedaghat, Sanaz , Mosley, Thomas H. , Gottesman, Rebecca F. , Jack, Clifford R. , Lutsey, Pamela L. , van Sloten, Thomas T

Mayo Clinic

Stroke | February 2, 2023 | Volume: 54 | Issue: Suppl_1 | Pages: No page available

10.1161/str.54.suppl_1.56 Get It

Introduction: Cardiovascular health may be used for prevention of cerebral vascular disease. We evaluated whether improvement of cardiovascular health within midlife and from midlife to late-life were each associated with lower prevalence of MRI markers of cerebral vascular disease at late-life. Methods: 1,638 participants from the Atherosclerosis Risk in Communities (ARIC) Study took part in two visits at midlife (mean ages 53 at ARIC visit 1 and 59 at visit 3), and a late-life visit (mean age 76). A cardiovascular health Life’s Simple 7 score (range 0-12/0-14, depending on diet availability) including six/seven items was calculated at each visit, with weight assigned to each item as poor (0), intermediate (1), or ideal (2). Participants underwent 3T brain MRI scans in 2011-2013 (late-life visit). Outcomes were white matter hyperintensity volume, microbleeds, and lacunar, subcortical, and cortical infarcts at late-life. Linear and logistic regression models were used to assess the associations of cardiovascular health with MRI markers of cerebral vascular disease. Results: Thirty nine percent of participants had high cardiovascular health at midlife visit 1, 32% at midlife visit 3, and 33% at late-life. Improvement of cardiovascular health within midlife and from midlife to late-life were each associated with a lower prevalence of cerebral vascular disease markers. For example, improvement in cardiovascular health (per point) from midlife to late-life was associated with smaller white matter hyperintensity volume (Beta:-0.07 [95%CI:-0.10,-0.04]), and lower odds of microbleeds (OR:0.93 [0.90,0.97]), lacunar (OR:0.93 [0.89,0.97)], subcortical (OR:0.93 [0.89,0.97])], and cortical infarcts (OR:0.92 [0.87,0.97)] (Figure). Conclusions: Improving cardiovascular health within midlife and from midlife to late-life may prevent development of cerebral vascular disease.
One-Stage Synovectomies Result in Improved Short-Term Outcomes Compared to Two-Stage Synovectomies of Diffuse-Type Tenosynovial Giant Cell Tumor (D-TGCT) of the Knee: A Multicenter, Retrospective, Cohort Study
Spierenburg, Geert , Verspoor, F.G.M. , Wunder, Jay S. , Griffin, Anthony M. , Houdek, Matthew T. , King, David M. , Boyle, Richard , Randall, R. Lor , Thorpe, Steven W. , Priester, Jacob , Geiger, Erik J. , Schreuder, Bart, Gelderblom, Hans , Sande, Michiel A. J. van de , Houdek, Matthew T , Randall, Robert Lor , Gelderblom, Hans , van de Sande, Michiel A J , Ferguson, Peter C. , Boyle, Richard, Heijden, Lizz van der , Bernthal, Nicholas M

Mayo Clinic

Cancers | February 2, 2023 | Volume: 15 | Issue: 3 | Pages: 941

10.3390/cancers15030941 | PMID 36765897 Get It

Diffuse-type tenosynovial giant cell tumors’ (D-TGCTs) intra- and extra-articular expansion about the knee often necessitates an anterior and posterior surgical approach to facilitate an extensive synovectomy. There is no consensus on whether two-sided synovectomies should be performed in one or two stages. This retrospective study included 191 D-TGCT patients from nine sarcoma centers worldwide to compare the postoperative short-term outcomes between both treatments. Secondary outcomes were rates of radiological progression and subsequent treatments. Between 2000 and 2020, 117 patients underwent one-stage and 74 patients underwent two-stage synovectomies. The maximum range of motion achieved within one year postoperatively was similar (flexion 123–120°, p = 0.109; extension 0°, p = 0.093). Patients undergoing two-stage synovectomies stayed longer in the hospital (6 vs. 4 days, p < 0.0001). Complications occurred more often after two-stage synovectomies, although this was not statistically different (36% vs. 24%, p = 0.095). Patients treated with two-stage synovectomies exhibited more radiological progression and required subsequent treatments more often than patients treated with one-stage synovectomies (52% vs. 37%, p = 0.036) (54% vs. 34%, p = 0.007). In conclusion, D-TGCT of the knee requiring two-side synovectomies should be treated by one-stage synovectomies if feasible, since patients achieve a similar range of motion, do not have more complications, but stay for a shorter time in the hospital.
Cardiovascular Events Among Survivors of Sepsis Hospitalization: A Retrospective Cohort Analysis
Jentzer, Jacob C. , Lawler, Patrick R. , Houten, Holly K. Van , Yao, Xiaoxi , Kashani, Kianoush , Dunlay, Shannon M. , Van Houten, Holly K , Kashani, Kianoush B , Jentzer, Jacob C , Lawler, Patrick , Yao, Xiaoxi , Dunlay, Shannon

Mayo Clinic

Journal of the American Heart Association | February 1, 2023 | Volume: 12 | Issue: 3 | Pages: No page available

10.1161/jaha.122.027813 | PMID 36722388 Get It

Background Sepsis is associated with an elevated risk of late cardiovascular events among hospital survivors. Methods and Results We included OptumLabs Data Warehouse patients from 2009 to 2019 who survived a medical/nonsurgical hospitalization lasting at least 2 nights. The association between sepsis during hospitalization, based on explicit and implicit discharge International Classification of Diseases, Ninth Revision ( ICD‐9 )/ Tenth Revision ( ICD‐10 ) diagnosis codes, with subsequent death and rehospitalization was analyzed using Kaplan–Meier survival analysis and multivariable Cox proportional‐hazards models. The study population included 2 258 464 survivors of nonsurgical hospitalization (5 396 051 total patient‐years of follow‐up). A total of 808 673 (35.8%) patients had a sepsis hospitalization, including implicit sepsis only in 448 644, explicit sepsis only in 124 841, and both in 235 188. Patients with sepsis during hospitalization had an elevated risk of all‐cause mortality (adjusted hazard ratio [HR], 1.27 [95% CI, 1.25–1.28]; P <0.001), all‐cause rehospitalization (adjusted HR, 1.38 [95% CI, 1.37–1.39]; P <0.001), and cardiovascular hospitalization (adjusted HR, 1.43 [95% CI, 1.41–1.44]; P <0.001), especially heart failure hospitalization (adjusted HR, 1.51 [95% CI, 1.49–1.53]). Patients with implicit sepsis had higher risk than those with explicit sepsis. A sensitivity analysis using the first hospitalization yielded concordant results for cardiovascular hospitalization (adjusted HR, 1.78 [95% CI, 1.76–1.78]; P <0.001), as did a propensity‐weighted analysis (adjusted HR, 1.52 [95% CI, 1.50–1.54]; P <0.001). Conclusions Survivors of sepsis hospitalization are at elevated risk of early and late post‐discharge death as well as cardiovascular and non‐cardiovascular rehospitalization. This hazard spans the spectrum of cardiovascular events and may suggest that sepsis is an important cardiovascular risk factor.
P788 Endoscopic management of patients with high-risk colorectal colitis-associated neoplasia: a Delphi study
Bak, M , Suzuki, Noriko , Matsumoto, Takayuki , Kiesslich, R, Coron, Emmanuel , Vries, Annemarie de , Hart, Adam , Pioche, M, Oldenburg, Bas , Bak, M, Albéniz, Eduardo , East, James E. , Coelho–Prabhu, Nayantara , Saitō, Yutaka , Banerjee, Rupa , Kaminski, Michal Filip , Woude, C. Janneke van der , Bisschops, Raf , Hart, A, Itzkowitz, Steven H. , Moons, Leon M.G.

Mayo Clinic

Journal of Crohn's and Colitis | January 30, 2023 | Volume: 17 | Issue: Supplement_1 | Pages: i920-i921

10.1093/ecco-jcc/jjac190.0918 Get It

Abstract Background Current guidelines recommend endoscopic resection of visible and endoscopically resectable colorectal colitis-associated neoplasia (CAN) in patients with inflammatory bowel disease (IBD). However, patients with high risk CAN are often not amenable to conventional resections techniques and a consensus approach for the endoscopic management of these lesions is presently lacking. This Delphi study aims to reach consensus amongst experts on the endoscopic management of these lesions. Methods A three-round modified Delphi process was conducted to reach consensus amongst worldwide IBD and/or endoscopy experts (n=18) from three continents. Experts were chosen based on the extensive clinical experience with IBD and/or EMR/ESD in patients with IBD, and the authorship on multiple peer-reviewed publications on CAN, the endoscopic resection of CAN and/or EMR/ESD. Consensus was considered if ≥ 75% agreed or disagreed. Quality of evidence was assessed by the criteria of the Cochrane Collaboration group. Results Consensus was reached on all statements (n=14). Experts agreed on a definition for CAN and high-risk CAN (HR-CAN). Consensus was reached on the examination of the colon with enhanced endoscopic imaging prior to resection, the endoscopic resectability of a HR-CAN lesion and endoscopic assessment and standard report of CAN lesions. In addition, experts agreed on type of resections of HR-CAN (&lt; 20mm, &gt;20 mm, with or without good lifting), endoscopic success (technical success and outcomes), histologic assessment and follow-up in HR-CAN. Conclusion This is the first step in developing international consensus-based recommendations for endoscopic management of (HR-)CAN. Although the quality of available evidence was considered low, consensus was reached on several aspects of the management of (HR-)CAN. The present work and proposed standardization might benefit future studies.
Impact of Tumor‐Infiltrating Lymphocytes on Disease Progression in Human Papillomavirus‐Related Oropharyngeal Carcinoma
Rivera, Michael , García, Joaquín J. , Lewis, Derrick B. , Lohse, Christine M. , Moore, Eric J. , Abel, Kathryn M. Van , Yin, Linda X , Bartemes, Kathleen R. , Van Abel, Kathryn M , Yin, Linda X. , Routman, David M. , Daniel, J.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 30, 2023 | Volume: 169 | Issue: 3 | Pages: 539-547

10.1002/ohn.249 | PMID 36939471 Get It

AbstractObjectiveWe aim to explore the prognostic value of tumor‐infiltrating lymphocytes (TILs) in the primary tumor and metastatic lymph nodes of patients with HPV(+)OPSCC. We hypothesize that TILS density at both sites is associated with disease‐free survival in HPV(+)OPSCC.Study DesignMatched case‐control study among HPV(+)OPSCC patients who underwent intent‐to‐cure surgery. Cases developed locoregional or distant recurrence. Controls were matched based on age, sex, pathologic T, N, and overall stage, year of surgery, type of adjuvant treatment received, and the Adult Comorbidity Evaluation‐27 (ACE‐27) score.SettingSingle tertiary care center, May 2007 to December 2016.MethodsTumoral TILs (tTILs) density was defined as % TILs; stromal TILs (sTILs) density was defined as absent/sparse or moderate/dense crowding. Associations between TILs and time to disease progression were assessed using Cox regression models.ResultsForty‐four case‐control pairs (N = 88) were included: 42 (48%) AJCC pStage I, 39 (44%) pStage II, and 7 (8%) pStage III. tTILs density ≥10% (hazard ratio [HR] 0.41, 95% confidence interval [CI] 0.17‐0.99, p = .048) and a moderate/dense sTILs density (HR 0.21, 95% CI 0.06‐0.75, p = .016) in the primary tumor were significantly associated with decreased risk of progression. TILs density in the lymph node was associated with decreased risk of progression but did not reach statistical significance. The tTILs and sTILs density correlated strongly between the primary tumor and lymph node. Concordance between the pathologists' was moderate (60%‐70%).ConclusionsIn HPV(+)OPSCC, a higher density of tumoral and stromal TILs in the primary tumor and possibly the lymph node may predict a lower risk of disease progression.
Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases
Harrison, Tabitha A. , Cao, Yin , Akimoto, Naohiko , Berndt, Sonja I. , Brenner, Hermann , Chang‐Claude, Jenny , Fujiyoshi, Kenji , Gallinger, Steven , Hoffmeister, Michael , Nishihara, Reiko , Pai, Rish K. , Slattery, Martha L. , Alwers, Elizabeth , Thibodeau, Stephen N. , Guelpen, Bethany Van , Woods, Michael O. , Zaidi, Syed Hassan Ejaz , Giannakis, Marios , Song, Mingyang , Phipps, Amanda I. , Peters, Ulrike , Ogino, Shuji , Hoffmeister, Michael , Cao, Yin , Harrison, Tabitha A , Van Guelpen, Bethany , Brenner, Hermann , Song, Mingyang , Ugai, Tomotaka , Haruki, Koichiro , Qu, Conghui , Chan, Andrew T. , Campbell, Peter T. , Buchanan, Daniel D. , Gunter, Marc J. , Hidaka, Akihisa , Hsu, Li , Jenkins, Mark A. , Milne, Roger L. , Moreno, Vı́ctor , Newcomb, Polly A. , Sakoda, Lori C. , Sun, Wei , Amitay, Efrat L. , Toland, Amanda Ewart , Potter, John D. , Nowak, Jonathan A.

Mayo Clinic

American Journal of Gastroenterology | January 28, 2023 | Volume: 118 | Issue: 4 | Pages: 712-726

10.14309/ajg.0000000000002171 | PMID 36707929 Get It

INTRODUCTION: Early-onset colorectal cancer diagnosed before the age of 50 years has been increasing. Likely reflecting the pathogenic role of the intestinal microbiome, which gradually changes across the entire colorectal length, the prevalence of certain tumor molecular characteristics gradually changes along colorectal subsites. Understanding how colorectal tumor molecular features differ by age and tumor location is important in personalized patient management. METHODS: Using 14,004 cases with colorectal cancer including 3,089 early-onset cases, we examined microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and KRAS and BRAF mutations in carcinomas of the cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum and compared early-onset cases with later-onset cases. RESULTS: The proportions of MSI-high, CIMP-high, and BRAF -mutated early-onset tumors were lowest in the rectum (8.8%, 3.4%, and 3.5%, respectively) and highest in the ascending colon (46% MSI-high; 15% CIMP-high) or transverse colon (8.6% BRAF -mutated) (all P trend <0.001 across the rectum to ascending colon). Compared with later-onset tumors, early-onset tumors showed a higher prevalence of MSI-high status and a lower prevalence of CIMP-high status and BRAF mutations in most subsites. KRAS mutation prevalence was higher in the cecum compared with that in the other subsites in both early-onset and later-onset tumors ( P < 0.001). Notably, later-onset MSI-high tumors showed a continuous decrease in KRAS mutation prevalence from the rectum (36%) to ascending colon (9%; P trend <0.001), followed by an increase in the cecum (14%), while early-onset MSI-high cancers showed no such trend. DISCUSSION: Our findings support biogeographical and pathogenic heterogeneity of colorectal carcinomas in different colorectal subsites and age groups.
Idiopathic Ventricular Tachycardia
Ward, Robert C. , Zyl, Martin van , Ward, Robert C , DeSimone, Christopher V.

Mayo Clinic

Journal of Clinical Medicine | January 26, 2023 | Volume: 12 | Issue: 3 | Pages: 930

10.3390/jcm12030930 | PMID 36769578 Get It

Idiopathic ventricular tachycardia (VT) is an important cause of morbidity and less commonly, mortality in patients with structurally normal hearts. Appropriate diagnosis and management are predicated on an understanding of the mechanism, relevant cardiac anatomy, and associated ECG signatures. Catheter ablation is a viable strategy to adequately treat and potentially provide a cure in patients that are intolerant to medications or when these are ineffective. In this review, we discuss special approaches and considerations for effective and safe ablation of VT arising from the right ventricular outflow tract, left ventricular outflow tract, left ventricular fascicles, papillary muscles, and moderator band.